Sven-erik H. Strand
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model.
Journal: Nuklearmedizin. Nuclear medicine
Published: March 18, 2025
Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: February 25, 2025
Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate.
Journal: International journal of molecular sciences
Published: May 23, 2024
Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin.
Journal: Scientific reports
Published: December 05, 2023
Recombinant α1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a 177Lu-DOTATATE Mouse Radiation Model.
Journal: Biomolecules
Published: April 19, 2023
Tumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 30, 2023
Small-scale dosimetry for alpha particle 241Am source cell irradiation and estimation of γ-H2AX foci distribution in prostate cancer cell line PC3.
Journal: EJNMMI physics
Published: March 18, 2022
Hematological Toxicity in Mice after High Activity Injections of 177Lu-PSMA-617.
Journal: Pharmaceutics
Published: February 22, 2022
Humanization, Radiolabeling and Biodistribution Studies of an IgG1-Type Antibody Targeting Uncomplexed PSA for Theranostic Applications.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 13, 2021
Kidney Protection with the Radical Scavenger α1-Microglobulin (A1M) during Peptide Receptor Radionuclide and Radioligand Therapy.
Journal: Antioxidants (Basel, Switzerland)
Published: June 15, 2021
177Lu-PSMA-617 Therapy in Mice, with or without the Antioxidant α1-Microglobulin (A1M), Including Kidney Damage Assessment Using 99mTc-MAG3 Imaging.
Journal: Biomolecules
Published: January 13, 2021
Last Updated: 09/26/2026